A Comparison of the Effects of Different Typographical Methods on the Recognizability of Printed Drug NamesOR, Calvin K. L; HAILIANG WANG.Drug safety. 2014, Vol 37, Num 5, pp 351-359, issn 0114-5916, 9 p.Article

A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scaleHANATANI, Tadaaki; SAI, Kimie; TOHKIN, Masahiro et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 9, pp 984-988, issn 1053-8569, 5 p.Article

Application of marginal structural models in pharmacoepidemiologic studies: a systematic reviewSHIBING YANG; EATON, Charles B; JUAN LU et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 6, pp 560-571, issn 1053-8569, 12 p.Article

Balancing benefit and risk of medicines: a systematic review and classification of available methodologiesMT-ISA, Shahrul; HALLGREEN, Christine E; QUARTEY, George et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 7, pp 667-678, issn 1053-8569, 12 p.Article

Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in TwitterFREIFELD, Clark C; BROWNSTEIN, John S; MENONE, Christopher M et al.Drug safety. 2014, Vol 37, Num 5, pp 343-350, issn 0114-5916, 8 p.Article

EU's New Pharmacovigilance Legislation: Considerations for BiosimilarsCALVO, Begoña; ZUNIGA, Leyre.Drug safety. 2014, Vol 37, Num 1, pp 9-18, issn 0114-5916, 10 p.Article

Enrollment and Monitoring of Women in Post-Approval Studies for Medical Devices Mandated by the Food and Drug AdministrationPINNOW, Ellen; HERZ, Naomi; LOYO-BERRIOS, Nilsa et al.Journal of women's health (Larchmont, N.Y. 2002). 2014, Vol 23, Num 3, pp 218-223, issn 1540-9996, 6 p.Article

Impact of a drug utilization review program on high-risk use of prescription controlled substancesDAUBRESSE, Matthew; GLEASON, Patrick P; YI PENG et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 4, pp 419-427, issn 1053-8569, 9 p.Article

Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank: Retrospective Evaluation against Emerging Safety SignalsCASTER, Ola; JUHLIN, Kristina; WATSON, Sarah et al.Drug safety. 2014, Vol 37, Num 8, pp 617-628, issn 0114-5916, 12 p.Article

Inappropriate prescribing: a systematic overview of published assessment toolsKAUFMANN, Carole P; TREMP, Regina; HERSBERGER, Kurt E et al.European journal of clinical pharmacology. 2014, Vol 70, Num 1, pp 1-11, issn 0031-6970, 11 p.Article

Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness researchHUYBRECHTS, Krista F; GERHARD, Tobias; FRANKLIN, Jessica M et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 8, pp 830-838, issn 1053-8569, 9 p.Article

Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendationsDAE HYUN KIM; SCHNEEWEISS, Sebastian.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 9, pp 891-901, issn 1053-8569, 11 p.Article

Medication use in adults living in Brasilia, Brazil: a cross-sectional, population-based studyGALVAO, Tais F; SILVA, Marcus T; GROSS, Raz et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 5, pp 507-514, issn 1053-8569, 8 p.Article

Observation stays in administrative claims databases: underestimation of hospitalized casesOVERMAN, Robert A; FREBURGER, Janet K; ASSIMON, Magdalene M et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 9, pp 902-910, issn 1053-8569, 9 p.Article

Ongoing Challenges in PharmacovigilanceDAL PAN, Gerald J.Drug safety. 2014, Vol 37, Num 1, pp 1-8, issn 0114-5916, 8 p.Article

Performance of Probabilistic Method to Detect Duplicate Individual Case Safety ReportsTREGUNNO, Philip Michael; FINK, Dorthe Bech; FERNANDEZ-FERNANDEZ, Cristina et al.Drug safety. 2014, Vol 37, Num 4, pp 249-258, issn 0114-5916, 10 p.Article

Selection bias in pharmacy-based patient surveysFRISK, P; KÄLVEMARK-SPORRONG, S; WETTERMARK, B et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 2, pp 128-139, issn 1053-8569, 12 p.Article

The upper bound to the Relative Reporting Ratio—a measure of the impact of the violation of hidden assumptions underlying some disproportionality methods used in signal detectionVAN HOLLE, Lionel; BAUCHAU, Vincent.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 8, pp 787-794, issn 1053-8569, 8 p.Article

Améliorer les soins en analysant le vécu des patients : ENSEMBLE, CONSTRUIRE UN PARTENARIAT ÉQUILIBRÉ AVEC LES PATIENTSTROTE, Jean-Claude; ALFARE, Patrick.La Revue Prescrire. 2014, Vol 34, Num 370, pp 581-587, issn 0247-7750, 7 p.Article

mediEVAL: un nouvel outil d'évaluation de la prise en charge médicamenteuse = mediEVAL: a New Evaluating Tool for the Medication-use SystemBESSONE, Marion; RATHELOT, Pascal; VANELLE, Patrice et al.Thérapie (Paris). 2014, Vol 69, Num 3, pp 195-206, issn 0040-5957, 12 p.Article

Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugsMARTIN-LATRY, Karin; CAZAUX, Julie; LAFITTE, Marianne et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 10, pp 1088-1092, issn 1053-8569, 5 p.Article

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)HOFFMAN, Keith B; DEMAKAS, Andrea R; DIMBIL, Mo et al.Drug safety. 2014, Vol 37, Num 11, pp 971-980, issn 0114-5916, 10 p.Article

Trimethoprim use before pregnancy and risk of congenital malformation: reanalyzed using a case-crossover design and a case-time-control designYUELIAN SUN; CHUN SEN WU; OLSEN, Jørn et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 10, pp 1076-1083, issn 1053-8569, 8 p.Article

Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settingsOKUYAN, Betul; SANCAR, Mesut; VEHBI IZZETTIN, Fikret et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 2, pp 209-214, issn 1053-8569, 6 p.Article

Cost-Effectiveness Acceptability Curves RevisitedAL, Maiwenn J.PharmacoEconomics (Auckland). 2013, Vol 31, Num 2, pp 93-100, issn 1170-7690, 8 p.Article